Developing first-in-class LRH-1 agonists to restore immune balance and induce intestinal mucosa healing.
Your Internet Explorer is outdated. For optimal security settings and a better experience on our site, try switching to one of these options:
Google Chrome
Firefox
Safari (macOS 10.8+ only)
